MetaVia, Inc. (MTVA)
1.38
-0.04
(-2.82%)
USD |
NASDAQ |
Apr 16, 09:51
MetaVia Research and Development Expense (Annual) : 6.802M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Aethlon Medical, Inc. | 2.212M |
| Tonix Pharmaceuticals Holding Corp. | 44.49M |
| Phio Pharmaceuticals Corp. | 4.618M |
| Jaguar Health, Inc. | 24.97M |
| Seastar Medical Holding Corp. | 7.518M |